Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic; Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
Int J Biol Macromol. 2024 May;266(Pt 2):130802. doi: 10.1016/j.ijbiomac.2024.130802. Epub 2024 Mar 15.
Tau protein is an intrinsically disordered protein that plays a key role in Alzheimer's disease (AD). In brains of AD patients, Tau occurs abnormally phosphorylated and aggregated in neurofibrillary tangles (NFTs). Together with Tau, 14-3-3 proteins - abundant cytosolic dimeric proteins - were found colocalized in the NFTs. However, so far, the molecular mechanism of the process leading to pathological changes in Tau structure as well as the direct involvement of 14-3-3 proteins are not well understood. Here, we aimed to reveal the effects of phosphorylation by protein kinase A (PKA) on Tau structural preferences and provide better insight into the interaction between Tau and 14-3-3 proteins. We also addressed the impact of monomerization-inducing phosphorylation of 14-3-3 at S58 on the binding to Tau protein. Using multidimensional nuclear magnetic resonance spectroscopy (NMR), chemical cross-linking analyzed by mass spectrometry (MS) and PAGE, we unveiled differences in their binding affinity, stoichiometry, and interfaces with single-residue resolution. We revealed that the interaction between 14-3-3 and Tau proteins is mediated not only via the 14-3-3 amphipathic binding grooves, but also via less specific interactions with 14-3-3 protein surface and, in the case of monomeric 14-3-3, also partially via the exposed dimeric interface. In addition, the hyperphosphorylation of Tau changes its affinity to 14-3-3 proteins. In conclusion, we propose quite complex interaction mode between the Tau and 14-3-3 proteins.
tau 蛋白是一种固有无序蛋白,在阿尔茨海默病(AD)中发挥关键作用。在 AD 患者的大脑中,tau 异常磷酸化并聚集在神经原纤维缠结(NFTs)中。与 Tau 一起,14-3-3 蛋白——丰富的细胞质二聚体蛋白——被发现共定位于 NFTs 中。然而,到目前为止,导致 Tau 结构发生病理变化的分子机制以及 14-3-3 蛋白的直接参与尚不清楚。在这里,我们旨在揭示蛋白激酶 A(PKA)磷酸化对 Tau 结构偏好的影响,并深入了解 Tau 和 14-3-3 蛋白之间的相互作用。我们还研究了 14-3-3 在 S58 处的单体诱导磷酸化对与 Tau 蛋白结合的影响。使用多维核磁共振波谱(NMR)、通过质谱(MS)和 PAGE 分析的化学交联,我们揭示了它们在结合亲和力、化学计量和单残基分辨率界面方面的差异。我们揭示了 14-3-3 和 Tau 蛋白之间的相互作用不仅通过 14-3-3 两亲性结合槽介导,还通过与 14-3-3 蛋白表面的非特异性相互作用介导,并且在单体 14-3-3 的情况下,也部分通过暴露的二聚体界面介导。此外,tau 的过度磷酸化改变了其与 14-3-3 蛋白的亲和力。总之,我们提出了 Tau 和 14-3-3 蛋白之间相当复杂的相互作用模式。